5-149981737-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000112.4(SLC26A2):c.2144C>T(p.Ala715Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000466 in 1,610,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A715T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000112.4 missense
Scores
Clinical Significance
Conservation
Publications
- achondrogenesis type IBInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, ClinGen
- atelosteogenesis type IIInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Ambry Genetics
- diastrophic dysplasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
- multiple epiphyseal dysplasiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- multiple epiphyseal dysplasia type 4Inheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152126Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000364 AC: 9AN: 247376 AF XY: 0.0000374 show subpopulations
GnomAD4 exome AF: 0.0000487 AC: 71AN: 1458710Hom.: 0 Cov.: 32 AF XY: 0.0000482 AC XY: 35AN XY: 725620 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74312 show subpopulations
ClinVar
Submissions by phenotype
Diastrophic dysplasia;C0265274:Achondrogenesis, type IB;C1847593:Multiple epiphyseal dysplasia type 4;C1850554:Atelosteogenesis type II Pathogenic:2
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 715 of the SLC26A2 protein (p.Ala715Val). This variant is present in population databases (rs104893918, gnomAD 0.01%). This missense change has been observed in individual(s) with SLC26A2-related skeletal dysplasia (PMID: 21077204). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4091). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC26A2 protein function with a positive predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on SLC26A2 function (PMID: 11448940, 15294877). For these reasons, this variant has been classified as Pathogenic. -
- -
Atelosteogenesis type II Pathogenic:1
- -
Achondrogenesis, type IB Pathogenic:1
- -
Multiple epiphyseal dysplasia type 4 Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at